185 related articles for article (PubMed ID: 28562258)
1. The Impact of Pediatric-Specific Vancomycin Dosing Guidelines: A Quality Improvement Initiative.
Miloslavsky M; Galler MF; Moawad I; Actis J; Cummings BM; El Saleeby CM
Pediatrics; 2017 Jun; 139(6):. PubMed ID: 28562258
[TBL] [Abstract][Full Text] [Related]
2. Cystatin C-Guided Vancomycin Dosing in Critically Ill Patients: A Quality Improvement Project.
Frazee E; Rule AD; Lieske JC; Kashani KB; Barreto JN; Virk A; Kuper PJ; Dierkhising RA; Leung N
Am J Kidney Dis; 2017 May; 69(5):658-666. PubMed ID: 28131530
[TBL] [Abstract][Full Text] [Related]
3. Assessment of vancomycin dosing and subsequent serum concentrations in pediatric patients.
Eiland LS; English TM; Eiland EH
Ann Pharmacother; 2011 May; 45(5):582-9. PubMed ID: 21521865
[TBL] [Abstract][Full Text] [Related]
4. Adherence to the 2009 consensus guidelines for vancomycin dosing and monitoring practices: a cross-sectional survey of U.S. hospitals.
Davis SL; Scheetz MH; Bosso JA; Goff DA; Rybak MJ
Pharmacotherapy; 2013 Dec; 33(12):1256-63. PubMed ID: 23897602
[TBL] [Abstract][Full Text] [Related]
5. An evaluation of vancomycin dosing for complicated infections in pediatric patients.
Durham SH; Simmons ML; Mulherin DW; Foland JA
Hosp Pediatr; 2015 May; 5(5):276-81. PubMed ID: 25934812
[TBL] [Abstract][Full Text] [Related]
6. Empirical Vancomycin Dosing in Pediatric Patients with Congenital Heart Disease and the Impact of Cardiopulmonary Bypass on Trough Concentrations.
Thomas CA; Picone A; Menon S; Willis BC
Pharmacotherapy; 2017 Nov; 37(11):1341-1346. PubMed ID: 28833385
[TBL] [Abstract][Full Text] [Related]
7. Changing the Time of Blood Collection to Determine Vancomycin Concentrations in Intensive Care Unit Patients.
Hammond DA; James TB; Atkinson LN; Painter JT; Lusardi K
Crit Care Nurse; 2018 Feb; 38(1):24-28. PubMed ID: 29437075
[TBL] [Abstract][Full Text] [Related]
8. Vancomycin trough concentrations in overweight or obese pediatric patients.
Heble DE; McPherson C; Nelson MP; Hunstad DA
Pharmacotherapy; 2013 Dec; 33(12):1273-7. PubMed ID: 23798327
[TBL] [Abstract][Full Text] [Related]
9. Simple approach to improving vancomycin dosing in intensive care: a standardised loading dose results in earlier therapeutic levels.
Truong J; Levkovich BJ; Padiglione AA
Intern Med J; 2012 Jan; 42(1):23-9. PubMed ID: 22276559
[TBL] [Abstract][Full Text] [Related]
10. Prospective evaluation of vancomycin therapeutic usage and trough levels monitoring.
Kabbara WK; El-Khoury G; Chamas NR
J Infect Dev Ctries; 2018 Nov; 12(11):978-984. PubMed ID: 32012127
[TBL] [Abstract][Full Text] [Related]
11. Allometric versus consensus guideline dosing in achieving target vancomycin trough concentrations.
Brown ML; Hutchison AM; McAtee AM; Gaillard PR; Childress DT
Am J Health Syst Pharm; 2017 Jul; 74(14):1067-1075. PubMed ID: 28522643
[TBL] [Abstract][Full Text] [Related]
12. Protocol versus Nonprotocol Dosing of Vancomycin in Neonates: A Single Center Evaluation of Steady State Trough Levels.
Schwartz ML; Wrobel J; Huntley J; Zeilmann C
Am J Perinatol; 2016 Jun; 33(7):678-82. PubMed ID: 26862722
[TBL] [Abstract][Full Text] [Related]
13. Achievement of Therapeutic Vancomycin Trough Serum Concentrations with Empiric Dosing in Neonatal Intensive Care Unit Patients.
Ringenberg T; Robinson C; Meyers R; Degnan L; Shah P; Siu A; Sturgill M
Pediatr Infect Dis J; 2015 Jul; 34(7):742-7. PubMed ID: 25629890
[TBL] [Abstract][Full Text] [Related]
14. A pre-postintervention study to evaluate the impact of dose calculators on the accuracy of gentamicin and vancomycin initial doses.
Hamad A; Cavell G; Hinton J; Wade P; Whittlesea C
BMJ Open; 2015 Jun; 5(6):e006610. PubMed ID: 26044758
[TBL] [Abstract][Full Text] [Related]
15. Performance of a divided-load intravenous vancomycin dosing strategy for obese patients.
Denetclaw TH; Yu MK; Moua M; Dowling TC; Steinke D
Ann Pharmacother; 2015 Aug; 49(8):861-8. PubMed ID: 25986008
[TBL] [Abstract][Full Text] [Related]
16. Safety and Outcome of Pharmacy-Led Vancomycin Dosing and Monitoring.
Momattin H; Zogheib M; Homoud A; Al-Tawfiq JA
Chemotherapy; 2016; 61(1):3-7. PubMed ID: 26555724
[TBL] [Abstract][Full Text] [Related]
17. Individualized vancomycin dosing in obese patients: a two-sample measurement approach improves target attainment.
Hong J; Krop LC; Johns T; Pai MP
Pharmacotherapy; 2015 May; 35(5):455-63. PubMed ID: 26011138
[TBL] [Abstract][Full Text] [Related]
18. Risk Factors for Non-Therapeutic Initial Steady-State Vancomycin Trough Concentrations in Children and Adolescents Receiving High Empiric Doses of Intravenous Vancomycin.
Buckel WR; Ghobrial S; Tamma PD; Milstone AM; Zhao Y; Hsu AJ
Paediatr Drugs; 2017 Feb; 19(1):43-51. PubMed ID: 27873214
[TBL] [Abstract][Full Text] [Related]
19. Vancomycin dosage requirements among pediatric intensive care unit patients with normal renal function.
Glover ML; Cole E; Wolfsdorf J
J Crit Care; 2000 Mar; 15(1):1-4. PubMed ID: 10757191
[TBL] [Abstract][Full Text] [Related]
20. High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity.
Hidayat LK; Hsu DI; Quist R; Shriner KA; Wong-Beringer A
Arch Intern Med; 2006 Oct; 166(19):2138-44. PubMed ID: 17060545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
